Yonatan Bilu

Yonatan Bilu

Auto-generated profile, based on publicly available information

Yonatan Bilu

KI Research Institute, Kfar Malal, Israel

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2023 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Open access
YBYonatan Bilu
Yonatan Bilu
NFNatalie Flaks-Manov
Natalie Flaks-Manov
MBMaytal Bivas-Benita
Maytal Bivas-Benita
PAPinchas Akiva
Pinchas Akiva
NKNir Kalkstein
Nir Kalkstein
SGShira Greenfeld
Shira Greenfeld
Adolescents' mental health was severely compromised during the COVID-19 pandemic. Longitudinal real-world studies on changes in the mental health of adolescents during the later phase of the pandemic are limited. We aimed to quantify the effect of COVID-19 pandemic on adolescents' mental health outcomes based on electronic health records. This was a retrospective cohort study using the computerized database of a 2.5 million members, state-mandated health organization in Israel. Rates of mental health diagnoses and psychiatric drug dispensations were measured among adolescents 12 to 17 years of age with and without pre-existing mental history, for the years 2017 to 2021. Relative risks were computed between the years, and interrupted time series (ITS) analyses evaluated changes in monthly incidence rates of psychiatric outcomes. The average population size was 218,146 in 2021. During the COVID-19 period, a 36% increase was observed in the incidence of depression (95% CI = 25-47), 31% in anxiety (95% CI = 23-39), 20% in stress (95% CI = 13-27), 50% in eating disorders (95% CI = 35-67), 25% in antidepressant use (95% CI = 25-33), and 28% in antipsychotic use (95% CI = 18-40). A decreased rate of 26% (95% CI = 0.80-0.88) was observed in ADHD diagnoses. The increase of the examined outcomes was most prominent among youth without psychiatric history, female youth, general secular Jewish population, youth with medium-high socioeconomic status, and those 14 to 15 years of age. ITS analysis confirmed a significantly higher growth in the incidence of psychiatric outcomes during the COVID-19 period, compared to those in previous years. This real-world study highlights the deterioration of adolescents' mental health during the COVID-19 pandemic and suggests that youth mental health should be considered during health policy decision making. We worked to ensure sex and gender balance in the recruitment of human participants. We worked to ensure race, ethnic, and/or other types of diversity in the recruitment of human participants. We actively worked to promote sex and gender balance in our author group. The author list of this paper includes contributors from the location and/or community where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work.

23 May 2023 in BJPsych Open
Verified
Journal Article
Open access
PDF file
YBYonatan Bilu
Yonatan Bilu
NKNir Kalkstein
Nir Kalkstein
EGEva Gilboa-Schechtman
Eva Gilboa-Schechtman
PAPinchas Akiva
Pinchas Akiva
GZGil Zalsman
Gil Zalsman
DADana Atzil-Slonim
Dana Atzil-Slonim
Background: Depression is a major cause of disability worldwide. Recent data suggest that, in industrialised countries, the prevalence of depression peaks in middle age. Identifying factors predictive of future depressive episodes is crucial for developing prevention strategies for this age group. Aims: We aimed to identify future depression in middle-aged adults with no previous psychiatric history. Method: To predict a diagnosis of depression 1 year or more following a comprehensive baseline assessment, we used a data-driven, machine-learning methodology. Our data-set was the UK Biobank of middle-aged participants (N = 245 036) with no psychiatric history. Results: Overall, 2.18% of the study population developed a depressive episode at least 1 year following baseline. Basing predictions on a single mental health questionnaire led to an area under the curve of the receiver operating characteristic of 0.66, and a predictive model leveraging the combined results of 100 UK Biobank questionnaires and measurements improved this to 0.79. Our findings were robust to demographic variations (place of birth, gender) and variations in methods of depression assessment. Thus, machine-learning-based models best predict diagnoses of depression when allowing the inclusion of multiple features. Conclusions: Machine-learning approaches show potential for being beneficial for the identification of clinically relevant predictors of depression. Specifically, we can identify, with moderate success, people with no recorded psychiatric history as at risk for depression by using a relatively small number of features. More work is required to improve these models and evaluate their cost-effectiveness before integrating them into the clinical workflow.

6 January 2022 in medRxiv
Verified
Preprint
Open access
PDF file
YBYonatan Bilu
Yonatan Bilu
NFNatalie Flaks-Manov
Natalie Flaks-Manov
MBMaytal Bivas-Benita
Maytal Bivas-Benita
PAPinchas Akiva
Pinchas Akiva
NKNir Kalkstein
Nir Kalkstein
SGShira Greenfeld
Shira Greenfeld
Importance: Adolescents’ mental health and well-being were severely compromised during the COVID-19 pandemic. Longitudinal follow-up studies, based on real-world data, assessing the changes in mental health of adolescents during the later phase of the COVID-19 pandemic are needed. Objective: To quantify the effect of COVID-19 on the incidence of Israeli adolescents’ mental health outcomes from electronic health record (EHR) data. Design, Setting and Participants: Retrospective cohort study analyzing EHR data of Maccabi Healthcare Services members, the second largest Health Maintenance Organization in Israel. Eligible subjects were 12-17 years old, during 2017-2021 with no previous diagnosis or psychiatric drug dispensation of those analyzed in this study. This resulted in over 200,000 eligible participants each year. Exposure: COVID-19 pandemic and the measures taken to mitigate it. Main Outcomes and Measures: Incidence rates of mental health diagnoses (depression; anxiety; obsessive-compulsive disorder; stress; eating disorders; ADHD), and psychiatric drugs dispensation (antidepressants; anxiolytics; antipsychotics; ADHD agents) were measured, and relative risks were computed between the years. Subgroup analyses were performed for age, gender, population sector and socioeconomic status. Interrupted time series (ITS) analysis evaluated changes in monthly incidence rates of psychiatric outcomes. Results: During the COVID-19 period a 36% increase was observed in the incidence of depression (95%CI: 25-47), 31% in anxiety (95%CI: 23-39), 20% in stress (95%CI: 13-27), 50% in eating disorders (95%CI: 35-67), 25% in antidepressants (95%CI: 25-33) and 28% in antipsychotics dispensation (95%CI: 18-40). Decreased rate of 26% (95% CI: 0.80-0.88) was observed in ADHD diagnoses and 10% (95% CI: 0.86-0.93) in prescriptions of ADHD agents. The increase was mostly attributed to females in the general Israeli population; nevertheless, a 24% increase in anxiety was seen in males (95%CI: 13-37), 64% in Israeli Arabs (95%CI: 12-140) and 31% in ultra-orthodox (95%CI: 3-67). ITS analysis revealed a significantly higher growth in the incidence of psychiatric outcomes during the COVID-19 period, compared to previous years. Conclusions and Relevance: EHR data of adolescents shows increased incidence rates of mental health diagnoses and medications during the COVID-19 pandemic, specifically identified females as those with the highest mental health burden. Our study highlights that the deteriorating mental health of children should be considered by decision-makers when actions and policies are put in place entering the third year of the pandemic. Key Points: Question: Has the COVID-19 pandemic and the strategies to contain it affected adolescents’ mental health? Findings: In this retrospective cohort study of over 200,000 adolescents 12–17 years old, the incidence rates of several measured mental health diagnoses and psychiatric medications increased significantly during the COVID-19 pandemic compared to the period before. This increase was mostly attributed to females. Meaning: This real-world study highlights the deterioration of adolescents’ mental health during the COVID-19 pandemic and suggests that the mental health of this young population should be considered during management and health policy decision making.

18 August 2023 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
YBYonatan Bilu
Yonatan Bilu
GAGuy Amit
Guy Amit
TSTamar Sudry
Tamar Sudry
PAPinchas Akiva
Pinchas Akiva
MTMeytal Avgil Tsadok
Meytal Avgil Tsadok
YSYair Sadaka
Yair Sadaka
Background: Developmental surveillance, conducted routinely worldwide, is fundamental for timely identification of children at risk of developmental delays. It is typically executed by assessing age-appropriate milestone attainment and applying clinical judgment during health supervision visits. Unlike developmental screening and evaluation tools, surveillance typically lacks standardized quantitative measures, and consequently, its interpretation is often qualitative and subjective. Objective: Herein, we suggested a novel method for aggregating developmental surveillance assessments into a single score that coherently depicts and monitors child development. We described the procedure for calculating the score and demonstrated its ability to effectively capture known population-level associations. Additionally, we showed that the score can be used to describe longitudinal patterns of development that may facilitate tracking and classifying developmental trajectories of children. Methods: We described the Developmental Surveillance Score (DSS), a simple-to-use tool that quantifies the age-dependent severity level of a failure at attaining developmental milestones based on the recently introduced Israeli developmental surveillance program. We evaluated the DSS using a nationwide cohort of >1 million Israeli children from birth to 36 months of age, assessed between July 1, 2014, and September 1, 2021. We measured the score’s ability to capture known associations between developmental delays and characteristics of the mother and child. Additionally, we computed series of the DSS in consecutive visits to describe a child’s longitudinal development and applied cluster analysis to identify distinct patterns of these developmental trajectories. Results: The analyzed cohort included 1,130,005 children. The evaluation of the DSS on subpopulations of the cohort, stratified by known risk factors of developmental delays, revealed expected relations between developmental delay and characteristics of the child and mother, including demographics and obstetrics-related variables. On average, the score was worse for preterm children compared to full-term children and for male children compared to female children, and it was correspondingly worse for lower levels of maternal education. The trajectories of scores in 6 consecutive visits were available for 294,000 children. The clustering of these trajectories revealed 3 main types of developmental patterns that are consistent with clinical experience: children who successfully attain milestones, children who initially tend to fail but improve over time, and children whose failures tend to increase over time. Conclusions: The suggested score is straightforward to compute in its basic form and can be easily implemented as a web-based tool in its more elaborate form. It highlights known and novel relations between developmental delay and characteristics of the mother and child, demonstrating its potential usefulness for surveillance and research. Additionally, it can monitor the developmental trajectory of a child and characterize it. Future work is needed to calibrate the score vis-a-vis other screening tools, validate it worldwide, and integrate it into the clinical workflow of developmental surveillance.

4 April 2025 in European Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
RNRachel Nega
Rachel Nega
RWRon Walfisch
Ron Walfisch
MTMichal Taler
Michal Taler
MEMartin Efron
Martin Efron
NBNurit El Bar
Nurit El Bar
DGDoron Gothelf
Doron Gothelf

1 October 2025 in JAMA Network Open
Verified
Journal Article
Open access
YBYonatan Bilu
Yonatan Bilu
GAGuy Amit
Guy Amit
KLKeren Mayer Lapidot
Keren Mayer Lapidot
NGNoa Gueron-Sela
Noa Gueron-Sela
NKNira Kerber
Nira Kerber
YSYair Sadaka
Yair Sadaka
Importance: Early childhood developmental surveillance is critical for identifying children at risk of developmental delays and ensuring timely intervention. Current well-child surveillance policies are not well designed to distinguish transient delays from persistent ones, potentially leading to unnecessary referrals or missed opportunities for early support. Objective: To evaluate whether the Tipat Halav Israeli Surveillance (THIS) developmental scale can be leveraged for distinguishing transient from persistent developmental delays and thus augment the precision of early childhood surveillance policies. Design, Setting, and Participants: This retrospective cohort study used national data from maternal child health clinics in Israel that perform routine developmental surveillance of children aged 0 to 6 years, serving approximately 65% of Israeli children. Participants were individuals born at 37 weeks’ gestation or later in the years 2014 to 2022 and assessed between January 1, 2014, and December 31, 2022, who failed to attain at least 1 developmental milestone between age 9 and 12 months based on their electronic health records. Analysis was done between July 2024 and April 2025. Exposure: Age-appropriate milestone attainment results at ages 9 to 12 months, along with demographic and birth-related covariates. Main Outcome and Measures: The primary outcome was ongoing milestone attainment failure at age 12 to 24 months. Accuracy of machine learning models trained to predict the outcome was measured by the area under the receiver operating characteristic curve, while for simpler decision rules, sensitivity and specificity were computed. Results: In a cohort of 529 797 infants born at 37 weeks’ gestation or later and assessed at age 9 to 12 months, developmental delays were observed in 37 760 (7.1%), among whom 20 862 (55.2%) were male and median gestational age was 39 weeks (IQR, 38-40 weeks). A total of 35 163 (93.1%) were assessed again in their subsequent year of life, among whom persistent delay was suggested for 8802 (25.0%). Machine learning models distinguished transient from persistent delays, with areas under the receiver operating characteristic curve ranging from 0.71 (95% CI, 0.70-0.72) to 0.77 (95% CI, 0.74-0.79). Simply counting the number of developmental domains in which unmet milestones occurred showed good fidelity as well (eg, sensitivity of 0.48 and specificity of 0.81 to identify persistent gross motor delay after early milestone failure in that domain plus 1 other). Conclusions and Relevance: This cohort study of infants showing early signs of developmental delay suggests that transient delays can be effectively distinguished from persistent ones using routine well-child surveillance data and also provides evidence for the validity of counting domains in which milestones are not attained, which is often used in practice. This suggests an accessible approach for developmental surveillance that may improve outcomes for children worldwide.